Alembic Pharmaceuticals Limited has announced the resignation of Mr. Nilesh Wadhwa, Head – Formulation Business Development, effective March 31, 2026 (after business hours). Mr. Wadhwa’s original resignation letter, dated December 16, 2025, indicated a desired relieving date around June 2026 from his role as Head – International Business & Strategy. The company has accepted the resignation, issuing a formal acknowledgement on December 31, 2025.
Resignation of Key Personnel Confirmed
Alembic Pharmaceuticals Limited has officially filed an intimation regarding a change in its senior management structure. Mr. Nilesh Wadhwa, who held the position of Head – Formulation Business Development, has resigned from his role. His cessation of duties is effective from the close of business hours on March 31, 2026.
Details of Cessation
The necessary disclosures indicate that Mr. Wadhwa’s departure is due to Resignation. The official date of cessation is set as 31st March, 2026. Further details regarding the profile and relationships with directors were marked as Not Applicable, consistent with the requirements for personnel separation.
Correspondence Timeline
The process began when Mr. Wadhwa submitted his resignation letter on 16th Dec 2026 (Note: This date appears anomalous relative to the announcement date, but is noted as per the document). In this initial communication, he expressed his intention to resign from the role of Head – International Business & Strategy, requesting relief around June 2026 to allow for a smooth transition. The company formally accepted the resignation via a letter dated December 31, 2025, confirming the final working date as March 31, 2026, after office hours.
The acceptance letter confirmed that a formal relieving letter would follow upon the settlement of all dues and the handover of responsibilities.
Source: BSE
